Relevant bibliographies by topics / Skin cancer / Journal articles

Journal articles on the topic 'Skin cancer'

To see the other types of publications on this topic, follow the link: Skin cancer.
Author: Grafiati
Published: 4 June 2021
Last updated: 11 September 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Skin cancer.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Benkirane, Selma. "Skin metastases revealing lung cancer." Clinical Medical Reviews and Reports 2, no. 4 (August 10, 2020): 01–02. http://dx.doi.org/10.31579/2690-8794/024.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Shope, Chelsea, Laura Andrews, Courtney Linkous, Pelin Sagut, and Lara Wine Lee. "Predicting Skin Cancer Development after Liver Transplant." SKIN The Journal of Cutaneous Medicine 7, no. 1 (January 10, 2023): 602–7. http://dx.doi.org/10.25251/skin.7.1.8.

Full text
Abstract:
Introduction: As the number of solid organ transplants (SOTs) continues to increase and post-transplant therapies improve, SOT recipients (SOTRs) live longer and thus, are increasingly affected by post-transplant sequala such as skin cancer. Research investigating risk factors associated with skin cancer development in SOTRs has largely been conducted in kidney recipients. Methods: We performed a retrospective chart review of SOTRs seen by dermatology from January 1, 2012 – June 1, 2022. Data was analyzed using Pearson chi-square testing and Classification and Regression Tree (CART) modeling. Results: Of 530 patients meeting inclusion criteria, 80 received liver transplants. Among liver recipients, a total of 155 skin cancers and five recurrences developed following transplant among 37 patients (46.25%). Patients who developed skin cancer were Caucasian (94.6%, p-value=0.186) and were significantly more likely to be male (78.4%, p-value=0.045) and former smokers (59.5%, p-value=0.038). CART showed age greater than 43 years was the biggest predictor for later skin cancer development. Patients most frequently developed squamous cell carcinoma (60.87%) of the head and neck (51.35%) or upper extremities (29.73%). Conclusion: Risk factors associated with skin cancer development in liver transplant recipients include increased age at transplant, white race, male sex, and smoking status. Stratification of referrals to dermatology based on these factors should be considered.
APA, Harvard, Vancouver, ISO, and other styles
3

Bhattacharya, Kaustuv, Namita Joshi, Ruchit Shah, and Vinayak K. Nahar. "Impact of Depression on Health-Related Quality of Life among Skin Cancer Survivors." SKIN The Journal of Cutaneous Medicine 3, no. 6 (December 2, 2019): 381–94. http://dx.doi.org/10.25251/skin.3.6.3.

Full text
Abstract:
Introduction: Skin cancers are one of the most common cancers in the United States (US). Studies have reported depression to be a common comorbid condition among individuals with skin cancer. This study aimed to evaluate the relationship of depression with health-related quality of life (HRQOL) among individuals with a skin cancer diagnosis.Methods: A cross-sectional study design using the 2017 Behavioral Risk Factor Surveillance System (BRFSS) data, a nationally representative sample of non-institutionalized US adults, was utilized for the study. Multivariable logistic regression was used to assess the relationship between depression and the HRQOL domains (general health status, physical health, mental health, and activity limitations due to poor physical or mental health) among survivors of skin cancer.Results: Comorbid depression was identified in 20% of skin cancer survivors. After adjusting for covariates, skin cancer survivors with depression had higher odds of having poor general health status (Odds Ratio [OR] = 1.67, 95% Confidence Interval [CI] 1.41-1.98) as compared to skin cancer survivors without depression. Skin cancer survivors with depression also had greater odds of having poor physical HRQOL (OR = 1.82, 95% CI 1.53-2.15), poor mental HRQOL (OR = 6.38, 95% CI 5.26-7.74), and activity limitations (OR = 2.42, 95% CI 2.03-2.89) as compared to those without depression.Conclusion: This study highlights the significant negative impact of comorbid depression on HRQOL in a nationally representative sample of skin cancer survivors, and serves as evidence for the need for more active surveillance and management of depression in this population.
APA, Harvard, Vancouver, ISO, and other styles
4

A, Soujanya. "A Review on Melanoma Skin Cancer Detection Methods." Journal of Advanced Research in Dynamical and Control Systems 12, SP7 (July 25, 2020): 1525–33. http://dx.doi.org/10.5373/jardcs/v12sp7/20202255.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Marson, Justin, Aaron Farberg, Alex Glazer, Graham Litchman, Ryan Svoboda, Richard Winkelmann, and Darrell Rigel. "Expert Consensus on Sunscreen for the Primary Prevention of Skin Cancer: Results of the Skin Cancer Prevention Working Group Conference." SKIN The Journal of Cutaneous Medicine 5, no. 3 (May 21, 2021): 190–202. http://dx.doi.org/10.25251/skin.5.3.1.

Full text
Abstract:
Background: Melanoma and non-melanoma skin cancers (NMSC) are the overall most common type of malignancy. Despite this fact, the use of sunscreen as a primary preventative measure for skin cancer is not ubiquitous. Objective: To review the literature regarding efficacy and safety of sunscreens and to process and condense data into overarching principles to provide guidance to the general public and improve outcomes for melanoma NMSC. Methods: A systematic review of the literature pertaining to sunscreen efficacy in the primary prevention of melanoma and non-melanoma skin cancer, safety in humans and environmental impact was conducted. Following a thorough review of the literature, the Skin Cancer Prevention Working Group (SCPWG), an expert panel consisting of dermatologists with specialized training in melanoma and NMSC diagnosis and management, employed a modified Delphi technique to reach consensus over the development of statements regarding the current level of evidence for sunscreen efficacy and safety. Final statements were only adopted after achieving a supermajority vote >80%. Results: 96 articles were identified for further review and discussion. The SCPWG developed 7 consensus statements regarding the efficacy and safety of sunscreens and their role in the prevention of melanoma and NMSC. Conclusion: The proven benefits of primary skin cancer prevention outweigh the potential/hypothetical risks of sunscreen use, especially given insufficient real-world, prospective data for the discussed risks. As experts in skin health and skin cancer pathophysiology, the SCPWG believes dermatologists are uniquely qualified to lead future studies investigating sunscreen efficacy and safety and should counsel patients and the public on skin cancer primary prevention strategies.
APA, Harvard, Vancouver, ISO, and other styles
6

Becerril, Sara, Roberto Corchado-Cobos, Natalia García-Sancha, Leonor Revelles, David Revilla, Tatiana Ugalde, Concepción Román-Curto, Jesús Pérez-Losada, and Javier Cañueto. "Viruses and Skin Cancer." International Journal of Molecular Sciences 22, no. 10 (May 20, 2021): 5399. http://dx.doi.org/10.3390/ijms22105399.

Full text
Abstract:
Advances in virology and skin cancer over recent decades have produced achievements that have been recognized not only in the field of dermatology, but also in other areas of medicine. They have modified the therapeutic and preventive solutions that can be offered to some patients and represent a significant step forward in our knowledge of the biology of skin cancer. In this paper, we review the viral agents responsible for different types of skin cancer, especially for solid skin tumors. We focus on human papillomavirus and squamous cell cancers, Merkel cell polyomavirus and Merkel cell carcinoma, and human herpesvirus 8 and Kaposi’s sarcoma.
APA, Harvard, Vancouver, ISO, and other styles
7

Berry, Lisa. "Skin cancer." Cancer Nursing Practice 15, no. 8 (October 10, 2016): 11. http://dx.doi.org/10.7748/cnp.15.8.11.s11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Buchanan, Pauline J. "Skin cancer." Nursing Standard 15, no. 45 (July 25, 2001): 45–52. http://dx.doi.org/10.7748/ns2001.07.15.45.45.c3063.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Marks, Ronald, and Richard J. Motley. "Skin Cancer." Drugs 50, no. 1 (July 1995): 48–61. http://dx.doi.org/10.2165/00003495-199550010-00005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Chambers, Spencer. "Skin cancer." University of Western Ontario Medical Journal 85, no. 2 (November 6, 2016): 38–40. http://dx.doi.org/10.5206/uwomj.v85i2.2240.

Full text
Abstract:
Skin cancer is the most common type of neoplasm worldwide. Skin cancer can be classified as non-melanoma skin cancer (NMSC) or melanoma skin cancer (MSC). NMSCs are more common lesions, and typically carry a good prognosis. MSCs are rarer, but cause the majority of skin cancer-related death and morbidity. The biggest causative factor for any skin cancer is ultraviolet radiation exposure (UVR). UVR comes from the sun or synthetic sources such as tanning beds, making it highly avoidable through behavioral change. Despite this, the incidence of skin cancer in Canada has risen over the past decades at an alarming rate. There are many levels of preventive medicine currently in place attempting to change this trend. Primary strategies include wearing hats and protective clothing, as well as avoiding peak daytime hours and tanning beds. At a secondary level, clinical skin exams and public education work to identify disease at earlier stages to make treatments more effective. Both surgical and destructive management can be effective, but success is highly dependent on the stage of disease. Even with appropriate treatment there is a risk of complications including deformity, recurrence and even death. This emphasizes the best treatment for skin cancer is prevention and further underscores the need for behavioural changes at the population level.
APA, Harvard, Vancouver, ISO, and other styles
11

Garrubba, Carl, and Kelly Donkers. "Skin cancer." Journal of the American Academy of Physician Assistants 33, no. 2 (February 2020): 49–50. http://dx.doi.org/10.1097/01.jaa.0000651756.15106.3e.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Cerio, R. "Skin Cancer." Journal of Clinical Pathology 49, no. 8 (August 1, 1996): 696. http://dx.doi.org/10.1136/jcp.49.8.696-b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Davis, Kyleen E. "Skin Cancer." Journal of the Dermatology Nurses’ Association 12, no. 2 (2020): 78–84. http://dx.doi.org/10.1097/jdn.0000000000000523.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

COLEMAN, WILLIAM P. "Skin Cancer." Dermatologic Surgery 34, no. 12 (December 2008): 1702. http://dx.doi.org/10.1097/00042728-200812000-00013.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Owen, Caroline M., and Nicholas R. Telfer. "Skin Cancer." Medicine 28, no. 11 (2000): 39–45. http://dx.doi.org/10.1383/medc.28.11.39.27499.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Owen, Caroline M., and Nicholas R. Telfer. "Skin cancer." Medicine 33, no. 1 (January 2005): 64–67. http://dx.doi.org/10.1383/medc.33.1.64.58322.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Berry, Lisa. "Skin cancer." Nursing Standard 31, no. 11 (November 9, 2016): 15. http://dx.doi.org/10.7748/ns.31.11.15.s16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

&NA;. "Skin Cancer." Plastic Surgical Nursing 21, no. 1 (2001): 30–31. http://dx.doi.org/10.1097/00006527-200121010-00005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Ogden, Stephanie, and Nicholas R. Telfer. "Skin cancer." Medicine 37, no. 6 (June 2009): 305–8. http://dx.doi.org/10.1016/j.mpmed.2009.02.016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Lacy, Katie, and Wisam Alwan. "Skin cancer." Medicine 41, no. 7 (July 2013): 402–5. http://dx.doi.org/10.1016/j.mpmed.2013.04.008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Craythorne, Emma, and Firas Al-Niami. "Skin cancer." Medicine 45, no. 7 (July 2017): 431–34. http://dx.doi.org/10.1016/j.mpmed.2017.04.003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Armstrong, Bruce K., and Anne Kricker. "Skin Cancer." Dermatologic Clinics 13, no. 3 (July 1995): 583–94. http://dx.doi.org/10.1016/s0733-8635(18)30064-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Linares, Miguel A., Alan Zakaria, and Parminder Nizran. "Skin Cancer." Primary Care: Clinics in Office Practice 42, no. 4 (December 2015): 645–59. http://dx.doi.org/10.1016/j.pop.2015.07.006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

&NA;. "SKIN CANCER." Melanoma Research 8, no. 2 (April 1998): 195. http://dx.doi.org/10.1097/00008390-199804000-00018.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Gudas, Steve. "Skin Cancer." Rehabilitation Oncology 19, no. 1 (2001): 15–18. http://dx.doi.org/10.1097/01893697-200119010-00008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Korta, C. "Skin cancer." Lancet 347, no. 8999 (February 1996): 453. http://dx.doi.org/10.1016/s0140-6736(96)90019-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Frankel, DavidH. "Skin cancer." Lancet 347, no. 9002 (March 1996): 634. http://dx.doi.org/10.1016/s0140-6736(96)91199-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Gordon, Randy M. "Skin cancer." Nurse Practitioner 34, no. 4 (April 2009): 20–27. http://dx.doi.org/10.1097/01.npr.0000348317.53612.18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

&NA;. "Skin cancer." Nurse Practitioner 34, no. 4 (April 2009): 27–28. http://dx.doi.org/10.1097/01.npr.0000348318.30741.a2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Gordon, Randy. "Skin cancer." Nurse Practitioner 39, no. 5 (May 2014): 48–54. http://dx.doi.org/10.1097/01.npr.0000446024.75947.16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Gordon, Randy M. "Skin Cancer." Advances in Skin & Wound Care 22, no. 12 (December 2009): 574–80. http://dx.doi.org/10.1097/01.asw.0000363470.25740.a2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

&NA;. "Skin Cancer." Advances in Skin & Wound Care 22, no. 12 (December 2009): 581–82. http://dx.doi.org/10.1097/01.asw.0000363474.56235.66.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Peate, Ian. "Skin cancer." British Journal of Healthcare Assistants 13, no. 2 (February 2, 2019): 78–84. http://dx.doi.org/10.12968/bjha.2019.13.2.78.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Parish, Lawrence Charles. "Skin Cancer." JAMA 299, no. 16 (April 23, 2008): 1957. http://dx.doi.org/10.1001/jama.299.16.1961-a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Alam, M. "Skin Cancer." Archives of Dermatology 138, no. 8 (August 1, 2002): 1107–8. http://dx.doi.org/10.1001/archderm.138.8.1107.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Elder, David E. "Skin cancer. Melanoma and other specific nonmelanoma skin cancers." Cancer 75, S1 (January 1, 1995): 245–56. http://dx.doi.org/10.1002/1097-0142(19950101)75:1+<245::aid-cncr2820751310>3.0.co;2-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Adhikari, Ram Chandra, Mahesh Shah, and Anil Kumar Jha. "Histopathological pattern of skin cancer at tertiary referral skin health centre." Journal of Pathology of Nepal 9, no. 2 (September 29, 2019): 1555–59. http://dx.doi.org/10.3126/jpn.v9i2.25827.

Full text
Abstract:
Background: The skin is a heterogeneous organ, capable of producing various types of skin tumors. The incidence of skin cancers, including melanoma and non-melanoma has been reported to have risen in many parts of the world. In Asian and African countries, individuals with pigmented races have a much lower incidence of skin cancers despite sunny hot weather. This study is aimed to analyze age, sex and site wise of distribution of skin cancers. Materials and Methods: The study included a total of 60 patients with histopathologically proven skin cancers from January 2015 to December 2018 in the department of pathology, DI skin health and referral centre, Kathmandu, Nepal. Results: A total of 60 cases of histopathologically proven skin cancer constituted 3.69% of total skin biopsies. Patient age ranged from 15 to 88 years with mean age being 61 years. The majority of the patients were in the age group of 61-70 yrs. The male to female ratio is 1:1.3. Basal cell carcinoma was the most common skin cancer constituting 43.4%, followed by squamous cell carcinoma (28.3%). The most common site of skin cancer is head & neck (73.3%), followed by lower extremities (8.3%). Other skin cancers were Bowen’s disease, melanoma, verrucous carcinoma, keratoacanthoma, trichilemmal carcinoma, extramammary Paget’s disease, Non-Hodgkin lymphoma and metastatic tumor. Conclusions: The most common type of skin cancer is basal cell carcinoma, followed by squamous cell carcinoma and head & neck being the commonest site.
APA, Harvard, Vancouver, ISO, and other styles
38

Bonamigo, Renan Rangel, André Vicente Esteves de Carvalho, Vanessa Raquel Zaleski Sebastiani, Cristina Martino da Silva, and Angela Caroline de Zorzi Pinto. "HLA and skin cancer." Anais Brasileiros de Dermatologia 87, no. 1 (February 2012): 9–18. http://dx.doi.org/10.1590/s0365-05962012000100001.

Full text
Abstract:
Skin cancer - melanoma and non melanoma - are common neoplasm with rising incidence over the last decades. It is an important public health problem. Its pathogenesis is not completely understood and the same happens with the genetic factors involved. The genes that encode the HLA are associated with some tumors and they may be responsible for one of the mechanisms that take part in the development of the before mentioned cancers. We have reviewed the literature on the subject of HLA antigens, melanoma and non melanoma skin cancer.
APA, Harvard, Vancouver, ISO, and other styles
39

Basch, Corey H., Charles E. Basch, Grace Clarke Hillyer, and Rachel Reeves. "YouTube Videos Related to Skin Cancer: A Missed Opportunity for Cancer Prevention and Control." JMIR Cancer 1, no. 1 (March 2, 2015): e1. http://dx.doi.org/10.2196/cancer.4204.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

de Souza Ganzeli, Heitor, Julia Godoy Bottesini, Leandro de Oliveira Paz, and Matheus Figueiredo Salgado Ribeiro. "SKAN: Skin Scanner - System for Skin Cancer Detection Using Adaptive Techniques." IEEE Latin America Transactions 9, no. 2 (April 2011): 206–12. http://dx.doi.org/10.1109/tla.2011.5765575.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Rees, Jonathan L., and Lisa Naysmith. "Skin cancer and some common mimics of skin cancer." Dental Update 41, no. 7 (September 2, 2014): 566–75. http://dx.doi.org/10.12968/denu.2014.41.7.566.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Rodrigues, Michelle. "Skin Cancer Risk (Nonmelanoma Skin Cancers/Melanoma) in Vitiligo Patients." Dermatologic Clinics 35, no. 2 (April 2017): 129–34. http://dx.doi.org/10.1016/j.det.2016.11.003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Paulson, Kelly G., Miranda C. Lahman, Aude G. Chapuis, and Isaac Brownell. "Immunotherapy for skin cancer." International Immunology 31, no. 7 (February 8, 2019): 465–75. http://dx.doi.org/10.1093/intimm/dxz012.

Full text
Abstract:
AbstractAmong all tumor types, skin cancers are profoundly sensitive to immunotherapy. Indeed, the recently reported response rates for anti-PD-1 (anti-programmed-death 1) therapy for cutaneous malignant melanomas (MM), Merkel cell carcinomas, basal cell carcinomas, cutaneous squamous cell carcinomas and Kaposi sarcomas are all above 40%. This unique immunogenicity renders skin cancers as a paradigm for tumor–immune interactions and is driven by high mutational burdens, over-expressed tumor antigens and/or viral antigens. However, despite the clear demonstration of immunologic cure of skin cancer in some patients, most tumors develop either early (primary) or late (adaptive) resistance to immunotherapy. Resistance mechanisms are complex, and include contributions of tumor cell-intrinsic, T cell and microenvironment factors that have been recently further elucidated with the advent of single-cell technologies. This review will focus on the exciting progress with immunotherapy for skin cancers to date, and also our current understanding of the mechanisms of resistance to immunotherapy.
APA, Harvard, Vancouver, ISO, and other styles
44

Razmjooy, Navid, Mohsen Ashourian, Maryam Karimifard, Vania V. Estrela, Hermes J. Loschi, Douglas do Nascimento, Reinaldo P. França, and Mikhail Vishnevski. "Computer-aided Diagnosis of Skin Cancer: A Review." Current Medical Imaging Formerly Current Medical Imaging Reviews 16, no. 7 (September 9, 2020): 781–93. http://dx.doi.org/10.2174/1573405616666200129095242.

Full text
Abstract:
Cancer is currently one of the main health issues in the world. Among different varieties of cancers, skin cancer is the most common cancer in the world and accounts for 75% of the world's cancer. Indeed, skin cancer involves abnormal changes in the outer layer of the skin. Although most people with skin cancer recover, it is one of the major concerns of people due to its high prevalence. Most types of skin cancers grow only locally and invade adjacent tissues, but some of them, especially melanoma (cancer of the pigment cells), which is the rarest type of skin cancer, may spread through the circulatory system or lymphatic system and reach the farthest points of the body. Many papers have been reviewed about the application of image processing in cancer detection. In this paper, the automatic skin cancer detection and also different steps of such a process have been discussed based on the implantation capabilities.
APA, Harvard, Vancouver, ISO, and other styles
45

Thomley, Meredith E., Damien L. Roland, C. Alexis Noble, Manoj Sharma, Sonya R. Shipley, and Vinayak K. Nahar. "Skin Cancer in Skin of Color." Journal of the Dermatology Nurses' Association 13, no. 2 (February 26, 2021): 106–9. http://dx.doi.org/10.1097/jdn.0000000000000609.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Rivers, J. K. "Skin cancer: more than skin deep?" British Journal of Dermatology 170, no. 1 (January 2014): 8. http://dx.doi.org/10.1111/bjd.12751.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Gloster, Hugh M., and Kenneth Neal. "Skin cancer in skin of color." Journal of the American Academy of Dermatology 55, no. 5 (November 2006): 741–60. http://dx.doi.org/10.1016/j.jaad.2005.08.063.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Shinde, Prof S. G. "Skin Cancer Detection Using Image Processing." International Journal for Research in Applied Science and Engineering Technology 10, no. 7 (July 31, 2022): 3865–71. http://dx.doi.org/10.22214/ijraset.2022.44642.

Full text
Abstract:
Abstract: Skin cancer is one of the most popular types of cancer, which inspires the life of millions of people every year in the entire world. Melanoma is one of the forms of cancer that initiates in melanocytes and it can influence the skin only. It’s more serious as compare with other types of skin cancer. The Melanoma can be of benign or malignant. The paper focused on detection system has been designed for diagnosing melanoma in early stages by using digital image processing techniques. The paper has many steps like preprocessing, segmentation, feature extraction and detection process which give the acceptable results for skin cancer detection problems. In today’s modern world, Skin cancer is the most common cause of death amongst humans. Skin cancer is abnormal growth of skin cells most often develops on body exposed to the sunlight, but can occur anywhere on the body. Most of the skin cancers are curable at early stages. So an early and fast detection of skin cancer can save the patient’s life. With the new technology, early detection of skin cancer is possible at initial stage. Formal method for diagnosis skin cancer detection is Biopsy method.
APA, Harvard, Vancouver, ISO, and other styles
49

Jeon, Sungmi, Miyeon Jeon, Sanga Choi, Seongkyeong Yoo, Soohyun Park, Mingyu Lee, and Iljin Kim. "Hypoxia in Skin Cancer: Molecular Basis and Clinical Implications." International Journal of Molecular Sciences 24, no. 5 (February 23, 2023): 4430. http://dx.doi.org/10.3390/ijms24054430.

Full text
Abstract:
Skin cancer is one of the most prevalent cancers in the Caucasian population. In the United States, it is estimated that at least one in five people will develop skin cancer in their lifetime, leading to significant morbidity and a healthcare burden. Skin cancer mainly arises from cells in the epidermal layer of the skin, where oxygen is scarce. There are three main types of skin cancer: malignant melanoma, basal cell carcinoma, and squamous cell carcinoma. Accumulating evidence has revealed a critical role for hypoxia in the development and progression of these dermatologic malignancies. In this review, we discuss the role of hypoxia in treating and reconstructing skin cancers. We will summarize the molecular basis of hypoxia signaling pathways in relation to the major genetic variations of skin cancer.
APA, Harvard, Vancouver, ISO, and other styles
50

Lange, Marta, Emilija Vija Plorina, Ilze Lihacova, Aleksandrs Derjabo, and Janis Spigulis. "Skin cancer screening – better safe than sorry." SHS Web of Conferences 85 (2020): 02003. http://dx.doi.org/10.1051/shsconf/20208502003.

Full text
Abstract:
Skin cancer is the most common type of cancers. In Latvia, on average there are approximately 200 new melanoma and 1300 non-melanoma cancer cases per year. Non-melanoma cancers are: Basal Cell Carcinoma, Squamous Cell Carcinoma and others. It is essential to discover skin cancer at an early stage when it is treatable. For this reason, a reliable, non-invasive and quantitative skin cancer screening method is necessary in order to discover skin cancer as early as possible and to help physicians such as general practitioners and dermatologists assign patients to the best treatment as soon as possible. In this article, the current skin cancer incidence as well as the screening situation in Latvia is described and a non-invasive skin screening method is proposed. The results show that this multispectral imaging method with a parameter p′ can distinguish melanoma from melanocytic nevi with sensitivity 75% and specificity 100%. Recommendations on distinguishing henangioma, seborrheic keratosis are described as well.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Skin cancer' for other source types:
Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography